Founder
AGEMICA
This company develops vaccines and therapies targeting aging and age-related diseases by leveraging artificial intelligence. They integrate extensive biological and clinical data, including information on cancers, drugs, and proteins, to accurately predict effective combination therapies. Their approach aims to create preventative vaccines for chronic diseases, potentially extending human healthspan.
- Artificial Intelligence
- Biotechnology
Updated 7 months ago
Funding
Raised to date
$500KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- This company develops vaccines and therapies targeting aging and age-related diseases by leveraging artificial intelligence. They integrate extensive biological and clinical data, including information on cancers, drugs, and proteins, to accurately predict effective combination therapies. Their approach aims to create preventative vaccines for chronic diseases, potentially extending human healthspan.